Nuria Martinez Velasco
Investigador pre-doc
Research group
Nuria Martínez graduated in Pharmacy in 2022 from San Jorge University.
She is currently a doctoral student in Drug Research, Development, and Control at the University of Barcelona.
Professional network profiles
Last Publications
- Lomba, L, Polo, A, Martinez N, Alejandre, J and Giner, B Solubility and Stability of Carvedilol in Deep Eutectic Solvents: A Step Towards a Sustainable Pharmaceutical Formulation in the Liquid State ChemistrySelect . 9(11): .
 - Pascual-Pastó G, Resa-Parés C, Castillo H, Aschero MR, Baulenas-Farrés M, Vilà-Ubach M, Burgeño-Sandoval V, Balaguer-Lluna L, Cuadrado-Vilanova M, Gene-Olaciregui N, Martinez N, Pérez-Jaume S, de Alava, E, Tirado, OM, Lavarino C, Mora J and Carcaboso AM Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma BIOCHEMICAL PHARMACOLOGY . 208: 115408-115408.
 - Lomba, L, Polo, A, Alejandre, J, Martinez N and Giner, B Solubility enhancement of caffeine and furosemide using deep eutectic solvents formed by choline chloride and xylitol, citric acid, sorbitol or glucose JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY . 79: .
 
Projects
- Project name:
 - Formación de doctores del programa nacional de formación de profesorado universitario 2022. Beneficiari: Núria Martínez
 - Leader
 - Angel Montero Carcaboso
 - Funding entities:
 - Ministerio De Universidades
 - Code
 - FPU22/00395
 - Starting - finishing date:
 - 2023 - 2027
 
- Project name:
 - Brain-penetrant medicines for diffuse infiltrative pediatric gliomas
 - Leader
 - Angel Montero Carcaboso
 - Funding entities:
 - Clientes Diversos
 - Code
 - PFNR0169
 - Starting - finishing date:
 - 2022 - 3000
 
News
- 
                            
Researchers at IRSJD develop a method to predict the efficacy of a potent nanomedicine in a severe childhood cancer
Researchers at IRSJD have developed a method that predicts the anticancer efficacy of nab-paclitaxel, a well-known nanomedicine, in mouse models, for treatment of Ewing sarcoma, a severe cancer affecting the bones and soft tissue of children and adolescents.